GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 346 filers reported holding GLOBUS MED INC in Q1 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $518 | +46.3% | 10,424 | +75.3% | 0.00% | 0.0% |
| Q2 2023 | $354 | +2.3% | 5,948 | -2.7% | 0.00% | 0.0% |
| Q1 2023 | $346 | -24.0% | 6,112 | -0.4% | 0.00% | 0.0% |
| Q4 2022 | $455 | -99.9% | 6,137 | -2.7% | 0.00% | 0.0% |
| Q3 2022 | $375,000 | +6.2% | 6,308 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $353,000 | -28.4% | 6,288 | -6.1% | 0.00% | 0.0% |
| Q1 2022 | $493,000 | -8.2% | 6,693 | -10.2% | 0.00% | 0.0% |
| Q4 2021 | $537,000 | +15.7% | 7,451 | +23.0% | 0.00% | 0.0% |
| Q3 2021 | $464,000 | +34.1% | 6,058 | +35.5% | 0.00% | 0.0% |
| Q2 2021 | $346,000 | +31.1% | 4,471 | +4.1% | 0.00% | 0.0% |
| Q1 2021 | $264,000 | -12.3% | 4,296 | -7.0% | 0.00% | 0.0% |
| Q4 2020 | $301,000 | +29.2% | 4,621 | -1.8% | 0.00% | 0.0% |
| Q3 2020 | $233,000 | -2.1% | 4,706 | -6.0% | 0.00% | 0.0% |
| Q2 2020 | $238,000 | – | 5,006 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 277,723 | $14,197,000 | 7.25% |
| Consonance Capital Management LP | 1,313,177 | $67,130,000 | 6.64% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 938,900 | $47,997,000 | 4.30% |
| Next Capital Management LLC | 111,098 | $5,679,000 | 3.81% |
| Godshalk Welsh Capital Management, Inc. | 83,305 | $4,259,000 | 3.76% |
| Global Alpha Capital Management Ltd. | 317,650 | $16,238,000 | 2.81% |
| Pembroke Management, LTD | 369,575 | $18,893,000 | 2.06% |
| Van Berkom & Associates Inc. | 1,528,936 | $78,159,000 | 1.92% |
| NUANCE INVESTMENTS, LLC | 865,872 | $44,263,000 | 1.67% |
| Bridge City Capital, LLC | 57,031 | $2,915,000 | 1.26% |